FDA.reportPublic FDA data

norethindrone acetate 5 MG Oral Tablet [Gallifrey]

RxCUI
2696255
RxNorm name
norethindrone acetate 5 MG Oral Tablet [Gallifrey]
Display name
norethindrone acetate 5 MG Oral Tablet [Gallifrey]
Full name
norethindrone acetate 5 MG Oral Tablet [Gallifrey]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GallifreyNORETHINDRONE ACETATEXiromed LLC26130af6-221b-2349-81b6-0c0132d6e5242024-08-31Warnings, Adverse reactionsExact identifier
rxcui: 2696255

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
26130af6-221b-2349-81b6-0c0132d6e524Gallifrey 5 MG Oral Tablet [PSN] · norethindrone acetate 5 MG Oral Tablet [Gallifrey] [SBD] · Gallifrey 5 MG Oral Tablet [SY]32Gallifrey TM (Norethindrone Acetate Tablets USP, 5 mg)20240831